Safety Study of BLZ-100 in Adult Subjects With Sarcoma Undergoing Surgery

NCT02464332 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Study did not enroll any subjects

Conditions

Sarcoma, Soft Tissue

Interventions

DRUG: BLZ-100

Sponsor

Blaze Bioscience Inc.

Collaborators

[object Object]